On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Dr Marco Sciacovelli graduated from the University of Padova (Italy) in 2007 with a first-class master’s degree in Pharmacy and then completed a PhD in Bioscience and Cellular Biology at the University of Padova in 2011 under the supervision of Prof Bernardi and Prof Rasola. His doctoral studies were focused on understanding the pro-tumorigenic role of the mitochondrial chaperone TRAP1 through regulation of the activity of Succinate Dehydrogenase (SDH) complex and intracellular succinate levels. After obtaining his PhD, he moved to Cambridge where he joined Dr Frezza’s laboratory at the MRC Cancer Unit in 2012 first as an MRC Career Development Postdoctoral Fellow and then in 2015 as a Research Associate after the unit joined the University of Cambridge. During the years of his postdoctoral training, he contributed to elucidating how the oncometabolite fumarate activates pro-oncogenic pathways through epigenetic and metabolic reprogramming in Fumarate Hydratase (FH)-deficient tumours. In 2022, he joined the University of Liverpool as a Tenure Track Fellow(Group Leader) to start his independent research program focused on understanding which distinctive metabolic traits are associated with colorectal cancers (CRC) progression.
